Journal of Clinical Virology
Volume 35, Issue 2 , Pages 130-134 , February 2006

Evaluation of a commercial assay for the detection of mumps specific IgM antibodies in oral fluid and serum specimens

  • Lenesha Warrener

      Affiliations

    • Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8327 6028; fax: +44 20 8205 8195.
    • ,
  • Dhanraj Samuel

      Affiliations

    • Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    • Microimmune Limited, 104A High Street, Brentford, Middlesex TW8 8AT, United Kingdom

Received 4 October 2005 ,Revised 18 October 2005 ,Accepted 19 October 2005.

References 

  1. Bjorvatn B. Incidence and persistence of mumps-specific IgM and IgA in the sera of mumps patients. Scand J Infect Dis. 1974;6:125–129
  2. Brown DWG, Ramsay MEB, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom 1991–1993. BMJ. 1994;308(6935):1015–1017
  3. Jin L, Beard S, Brown DWG. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis. 1999;180:829–833
  4. Jin L, Brown DWG, Litton PA, White JM. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis. 2004;189:1001–1008
  5. Meurman O, Hanninen P, Krishna RV, Ziegler T. Determination of IgG- and IgM-class antibodies to mumps virus by solid-phase enzyme immunoassay. J Virol Methods. 1982;4:249–257
  6. Parry JV. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Ann N Y Acad Sci. 1993;694:216–233
  7. Perry KR, Brown DWG, Parry JV, Panday S, Pipkin C, Richards A. Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol. 1993;40:235–240
  8. Rice PS, Cohen BJ. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol Infect. 1996;116(3):331–338
  9. Samuel D, Sasnauskas K, Jin L, Beard S, Zvirbliene A, Gedvilaite A, et al. High level expression of recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology. J Med Virol. 2002;66:123–230
  10. Samuel D, Sasnauskas K, Jin L, Gedvilaite A, Slibinskas R, Beard S, et al. Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae. J Clin Virol. 2003;28:121–129
  11. Vyse AJ, Knowles WA, Cohen BJ, Brown DWG. Detection of IgG antibody to Epstein–Barr virus viral capsid antigen in saliva by antibody capture radioimmunoassay. J Virol Methods. 1997;6:93–101
  12. Vyse AJ, Cohen BJ, Ramsay ME. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health. 2001;115(3):201–207
  13. Vyse AJ, Gay NJ, White JM, Ramsay ME, Brown DWG, Cohen BJ, et al. Evolution of surveillance of measles, mumps and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev. 2002;24(2):125–136

PII: S1386-6532(05)00297-0

doi: 10.1016/j.jcv.2005.10.008

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 130-134 , February 2006

Article Tools